Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Refine Sector
Sub-Category
Clear
Publish Date
Clear
Region
Clear
Clear All
Sort by:
Global Orphan and Rare Dermatology Drugs Market to 2024 – An Increasingly Competitive Landscape as New Companies Enter the Market with Novel Products, Driving Strong Market Growth

Published: Sep-2018

Dermatology is a highly diverse therapy area, in terms of severity and clinical presentation, which deals with diseases.....

$4995
More Info
Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy

Published: Sep-2018

Heart failure (HF) is a life-threatening syndrome with substantial morbidity and mortality. There are more than 26 million.....

$4995
More Info
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 – Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Published: Jul-2018

Osteoporosis is a “silent epidemic” and as per the WHO declarations, it is a priority health issue. Osteoporosis.....

$4995
More Info
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

Published: Jul-2018

Cancer immunotherapy, which can predominantly be classed as a form of targeted therapy, drives an immune response against.....

$4995
More Info
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 – Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Published: Jul-2018

Colorectal cancer (CRC) is the most common cancer and the leading cause of cancer-related mortality globally. The five-year.....

$4995
More Info
Psoriasis Therapeutics in Asia-Pacific Markets to 2024: Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

Published: Jun-2018

Psoriasis is a common, chronic inflammatory skin condition affecting around 2–3% of the world’s population......

$4995
More Info
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

Published: May-2018

Breast cancer is the second most common cancer in the world overall, and the most common cancer in women. When diagnosed.....

$4995
More Info
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

Published: Mar-2018

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects.....

$4995
More Info
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

Published: Mar-2018

Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5–7% of people in Western.....

$4995
More Info
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

Published: Mar-2018

Hereditary Angioedema (HAE) is a rare genetic disorder caused by a lack of a sufficient amount of a protein called C1.....

$4995
More Info
Sort by: